Hydroquinone for skin lightening: Safety profile, duration of use and when should we stop?

@article{Tse2010HydroquinoneFS,
  title={Hydroquinone for skin lightening: Safety profile, duration of use and when should we stop?},
  author={T. Tse},
  journal={Journal of Dermatological Treatment},
  year={2010},
  volume={21},
  pages={272 - 275}
}
  • T. Tse
  • Published 2010
  • Medicine
  • Journal of Dermatological Treatment
Abstract Hydroquinone has been marketed in skin-lightening products for almost 50 years and remains as the most frequently used whitening constituent in the category. Issues and concerns have been raised regarding its potential dermatological and systemic side effects. These almost led to it being banned from the US market by the FDA in 2006. This article reviews its safety profile. The author also suggests on the duration of its use and advises on regular assessments by medical physicians. 
43 Citations

Topics from this paper

Hydroquinone: myths and reality
Hydroquinone-induced depigmentation: case report and review of the literature.
The dangers of skin-lightening creams
Cosmeceuticals for Hyperpigmentation: What is Available?
Tranexamic acid: an important adjuvant in the treatment of melasma
Chemical leukoderma due to hydroquinone: An unusual phenomenon
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Hydroquinone and its analogues in dermatology – a risk‐benefit viewpoint
Skin lightening preparations and the hydroquinone controversy
The safety of hydroquinone
Complications of chronic use of skin lightening cosmetics
Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams
Exogenous ochronosis: An overview
The safety of hydroquinone: a dermatologist's response to the 2006 Federal Register.
  • J. Levitt
  • Medicine
  • Journal of the American Academy of Dermatology
  • 2007
Disorders of hyperpigmentation.
Hydroquinone-induced localized exogenous ochronosis treated with dermabrasion and CO2 laser.
...
1
2
3
4
...